CD44 and breast cancer: Subsequently, CSCs were identified in solid tumours by Al-Hajj and co-workers who reported in 2003 that only a subpopulation of breast cancer cells staining, positively for CD44 and negatively for CD24, could re­ initiate tumours with the cellular heterogeneity typical of the original tumour.1